About James Huang
Form D filings for Actym Therapeutics in 2020 list James Huang as director.
James Huang first appears on SEC filings in 2020.
Experience
This experience comes from SEC filings. The years are when the filings name James Huang in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people James Huang works with at each company, as listed on that company's latest Form D.
Actym Therapeutics, Inc. · Form D, Apr 9, 2020